Orsi Giricz, Ph.D

Dr. Orsi Giricz joined the LLS Research Team as the Director of Research Programs in September 2018.  Orsi brings more than 15 years of academic research experience to the organization, in both solid and liquid tumors. She works with other LLS scientists to develop and implement new transformative research programs while also monitoring/evaluating our currently supported grants.

Prior to joining LLS, Dr. Giricz was a Faculty Associate and Senior Scientist at the Albert Einstein College of Medicine, where her research focused on different blood cancers. She was the project leader on the Fire Department of New York/Einstein/Memorial Sloan Kettering Cancer Center collaboration - screening all 9/11 first responders for early signs of hematological malignancies (first study recently published in JAMA Oncology, June 2018 issue). She also studied mechanisms of drug/CAR-T resistance in acute lymphoblastic leukemia. Orsi has published in numerous peer reviewed journals and still actively contributes to on-going blood cancer research. Dr. Giricz received her Master’s in Molecular Biology and Immunology from Eötvös Loránd University in Hungary, and her Doctorate in Biochemistry from Florida Atlantic University. She completed her post-doctoral training at Einstein, focusing on cancer biology of solid tumors such as cutaneous malignant melanoma and triple negative breast cancer.